Literature DB >> 30523621

Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Associated Disease in the AIDS Patient: An Update.

Dirk P Dittmer1, Blossom Damania2.   

Abstract

In this book chapter, we review the current knowledge of the biology and pathogenesis of Kaposi's sarcomaassociated herpesvirus (KSHV). We describe the lifecycle of KSHV, the cancers associated with this virus, as well as current treatment modalities.

Entities:  

Mesh：

Year:  2019        PMID： 30523621      PMCID： PMC7201581          DOI： 10.1007/978-3-030-03502-0_3

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


  101 in total

1.  Immune deficiency and risk for malignancy among persons with AIDS.

Authors:  Sam M Mbulaiteye; Robert J Biggar; James J Goedert; Eric A Engels
Journal:  J Acquir Immune Defic Syndr       Date:  2003-04-15       Impact factor: 3.731

2.  Occurrence of Kaposi's sarcoma in renal transplant recipients treated with low doses of cyclosporine.

Authors:  G Civati; G Busnach; B Brando; M L Broggi; C Brunati; G P Casadei; L Minetti
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

3.  Kaposi's sarcoma in Malawi: a continued problem for HIV-positive and HIV-negative individuals.

Authors:  Kurtis M Host; Marie-Josephe Horner; Toon van der Gronde; Agnes Moses; Sam Phiri; Dirk P Dittmer; Blossom Damania; Satish Gopal
Journal:  AIDS       Date:  2017-01-14       Impact factor: 4.177

4.  Relationship of HHV8 replication and Kaposi's sarcoma after solid organ transplantation.

Authors:  J C Mendez; G W Procop; M J Espy; T F Smith; C G McGregor; C V Paya
Journal:  Transplantation       Date:  1999-04-27       Impact factor: 4.939

5.  Imatinib-induced regression of AIDS-related Kaposi's sarcoma.

Authors:  Henry B Koon; Glenn J Bubley; Liron Pantanowitz; David Masiello; Brad Smith; Katherine Crosby; Joann Proper; Will Weeden; Thomas E Miller; Pamela Chatis; Merrill J Egorin; Steven R Tahan; Bruce J Dezube
Journal:  J Clin Oncol       Date:  2004-11-30       Impact factor: 44.544

6.  KSHV-induced notch components render endothelial and mural cell characteristics and cell survival.

Authors:  Ren Liu; Xiuqing Li; Anil Tulpule; Yue Zhou; Jeffrey S Scehnet; Shaobing Zhang; Jong-Soo Lee; Preet M Chaudhary; Jae Jung; Parkash S Gill
Journal:  Blood       Date:  2009-11-24       Impact factor: 22.113

7.  Distribution of Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 in maternal saliva and breast milk in Zambia: implications for transmission.

Authors:  Brad P Brayfield; Chipepo Kankasa; John T West; Jubra Muyanga; Ganapati Bhat; Winslow Klaskala; Charles D Mitchell; Charles Wood
Journal:  J Infect Dis       Date:  2004-05-25       Impact factor: 5.226

8.  Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

Authors:  V Beral; T A Peterman; R L Berkelman; H W Jaffe
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

9.  KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition.

Authors:  Fang Cheng; Pirita Pekkonen; Simonas Laurinavicius; Nami Sugiyama; Stephen Henderson; Thomas Günther; Ville Rantanen; Elisa Kaivanto; Mervi Aavikko; Grzegorz Sarek; Sampsa Hautaniemi; Peter Biberfeld; Lauri Aaltonen; Adam Grundhoff; Chris Boshoff; Kari Alitalo; Kaisa Lehti; Päivi M Ojala
Journal:  Cell Host Microbe       Date:  2011-12-15       Impact factor: 21.023

10.  Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study.

Authors:  Nader Kim El-Mallawany; William Kamiyango; Jeremy S Slone; Jimmy Villiera; Carrie L Kovarik; Carrie M Cox; Dirk P Dittmer; Saeed Ahmed; Gordon E Schutze; Michael E Scheurer; Peter N Kazembe; Parth S Mehta
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240
View more
  5 in total

1.  Whole-genome sequencing of Kaposi sarcoma-associated herpesvirus (KSHV/HHV8) reveals evidence for two African lineages.

Authors:  Razia Moorad; Angelica Juarez; Justin T Landis; Linda J Pluta; Megan Perkins; Avery Cheves; Dirk P Dittmer
Journal:  Virology       Date:  2022-02-02       Impact factor: 3.616

Review 2.  Control of Viral Latency by Episome Maintenance Proteins.

Authors:  Alessandra De Leo; Abram Calderon; Paul M Lieberman
Journal:  Trends Microbiol       Date:  2019-10-14       Impact factor: 17.079

3.  The potential impacts of early secreted antigenic target of 6 kDa of Mycobacterium tuberculosis on KSHV-infected cells.

Authors:  Lu Dai; Bock-Gie Jung; Jungang Chen; Buka Samten; James Craig Forrest; Steven R Post; Zhiqiang Qin
Journal:  J Med Virol       Date:  2020-07-17       Impact factor: 20.693

4.  Identification of AIDS-Associated Kaposi Sarcoma: A Functional Genomics Approach.

Authors:  Peng Zhang; Jiafeng Wang; Xiao Zhang; Xiaolan Wang; Liying Jiang; Xuefeng Gu
Journal:  Front Genet       Date:  2020-01-24       Impact factor: 4.599

Review 5.  Management of HIV-infected patients in the intensive care unit.

Authors:  François Barbier; Mervin Mer; Piotr Szychowiak; Robert F Miller; Éric Mariotte; Lionel Galicier; Lila Bouadma; Pierre Tattevin; Élie Azoulay
Journal:  Intensive Care Med       Date:  2020-02-03       Impact factor: 17.440
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.